ClinicalTrials.gg
RecruitingNCT05609084REPREOUpdated Nov 20, 2026

Intensive Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy

An interventional study of Speech therapy and Speech therapy assessment in Epilepsy, Anomia and Temporal Lobe Epilepsy, sponsored by Assistance Publique Hopitaux De Marseille. Recruiting at 12 sites in France. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.

Primary conditionEpilepsy, Temporal LobeRegistry: EpilepsyReclassifiedWhy we changed it
Registry
Epilepsy — the first condition term the registry derived for this study.
ClinicalTrials.gg
Epilepsy, Temporal Lobe
Why
  1. The study's listed conditions name Epilepsy, Temporal Lobe, a narrower term within Epilepsy.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Assistance Publique Hopitaux De Marseille · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Mar 2023; still recruiting 3 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
214
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

Out of 30,000 new cases per year in France, 30% of epileptic patients are drug-resistant. Neurosurgery, which consists in resecting the epileptogenic zone, is the only chance of cure. In the case of temporal epilepsy of the language-dominant hemisphere (TLE), this procedure presents a high risk of increasing cognitive difficulties and may even be contraindicated for this reason alone. The difficulties found are impairments in lexical access (anomia) and verbal memory and affect more than 60% of patients . Preoperative cognitive rehabilitation could influence brain plasticity mechanisms but there are currently no recommendations on this topic. In this context, the investigators have developed a speech rehabilitation procedure specific to the needs of ELTPR patients. They rely on cognitive hypotheses explaining the disorders but also on models of rehabilitation-induced neural plasticity likely to improve cognitive reserve before surgery. The investigators hypothesize that preoperative cognitive language rehabilitation in ELTPR patients may decrease surgical risk and improve postoperative language prognosis.

The primary objective is to demonstrate the protective efficacy of preoperative speech rehabilitation on language performance postoperatively.

02

Conditions studied

  • Epilepsy
  • Anomia
  • Temporal Lobe Epilepsy

Browse trials for

03

In context

Epilepsy, Temporal Lobe Reclassified

65 studies on the registry are indexed under Epilepsy, Temporal Lobe; 25 are open to participants now.

This study's planned enrollment of 214 is above the median of 30 across 41 interventional studies indexed under Epilepsy, Temporal Lobe.

Browse Epilepsy, Temporal Lobe studies →

Lead sponsor

Assistance Publique Hopitaux De Marseille is the lead sponsor of 702 studies on the registry; 139 are open to participants now.

Compared within Epilepsy, Temporal Lobe, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Epilepsy. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patient 16 years of age and older,
  2. Patient whose epileptogenic area involves the temporal structures of the hemisphere specialized for language,
  3. Patient whose hemispheric specialization for language is known
  4. Patient willing to undergo resective surgery such as anterior temporal lobectomy or resection in the temporal lobe involving the hippocampus and/or the baso-temporal language area and whose planned surgery date is compatible with the performance of the study,
  5. Patient with a known NTB score
  6. Patient who has signed an or patient whose parents or legal guardians have signed the informed consent (or a single parent or legal guardian if applicable)
  7. Patient whose first language is French (1st language learned by the patient),
  8. Patient declaring to be familiar with the use of a computer and having access to an internet connection from home
  9. Patient affiliated or benefiting from a social security system.

Exclusion criteria

Exclusion Criteria:

  1. Patient with a speech disorder that may impair intelligibility and compromise the use of the interface;
  2. Patient with an uncorrected hearing impairment,
  3. Patients with a total intelligence quotient (IQ) \<70 (assessed in the context of care, in the year preceding the surgical procedure)
  4. Patients who are pregnant, nursing, deprived of liberty, under guardianship or curatorship.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
214 participants (estimated)

Study arms

  • Other
    Control

    Patients will have speech therapy assessment in addition to standard care.

    Procedure: Speech therapy assessment

  • Experimental
    Experimental

    Patients will have speech therapy assessment and intensive speech rehabilitation

    Procedure: Speech therapy · Procedure: Speech therapy assessment

Interventions

  • ProcedureSpeech therapy

    Patients will connect on an interface to pratice speech therapy

  • ProcedureSpeech therapy assessment

    Patients will be followed by an speech therapist

06

What researchers measure

Primary outcomes

  1. Effect of rehabilitation on immediate postoperative performances

    Number of images quoted

    Time frame: Day 7 after surgery

Secondary outcomes

  1. Impact of rehabilitation on long-term postoperative performance

    Number of images quoted

    Time frame: 6 months after surgery

  2. Impact of rehabilitation on immediate on standardized language tests

    % of correct answers of language tests

    Time frame: Day 7 after surgery

  3. Impact of rehabilitation on long-term postoperative performance on standardized language tests

    % of correct answers of language tests

    Time frame: 6 months after surgery

  4. Impact of preoperative rehabilitation on verbal memory

    Verbal memory task

    Time frame: Day 7 after surgery

  5. Impact of preoperative rehabilitation on verbal memory

    Verbal memory task

    Time frame: 6 months after surgery

  6. Lexical fluency

    Lexical evocation tests limited to 2 minutes according to a formal criterion or an imposed categorical criterion

    Time frame: Day 7 after surgery

  7. Lexical fluency

    lexical evocation tests limited to 2 minutes according to a formal criterion or an imposed categorical criterion

    Time frame: 6 months after surgery

  8. Denomination of control lists

    Number of words quoted

    Time frame: Day 7 after surgery

  9. Denomination of control lists

    Number of words quoted

    Time frame: 6 months after surgery

  10. Self-reported perception of anomia

    Use of an ad-hoc scale graduated from 0 (no complaint) to 10 (maximum complaint)

    Time frame: Day 7 after surgery

  11. Self-reported perception of anomia

    Ad-hoc scale graduated from 0 (no complaint) to 10 (maximum complaint)

    Time frame: 6 months after surgery

  12. Evaluation of Quality of life

    Quality Of Life in Epilepsy Inventory (QOLIE-31) (0 meaning better outcome, highest score meaning worse outcome)

    Time frame: Day 7 after surgery

  13. Evaluation of Quality of life

    Quality Of Life in Epilepsy Inventory (QOLIE-31) (0 meaning better outcome, highest score meaning worse outcome)

    Time frame: 6 months after surgery

  14. Impact of pre-operative rehabilitation on the number of post-operative rehabilitation sessions

    Number of speech therapy sessions performed postoperatively

    Time frame: 6 months after surgery

07

Study locations

6 of 12 sites recruiting
  • Service EFSN - Hôpital Pellegrin
    Bordeaux, France
    Recruiting
    • Véronique Michel · Contact
  • Service de Neurologie de l'Epilepsie - CHU Grenoble-Alpes
    Grenoble, France
    Recruiting
    • LORELLA MINOTTI · Contact
  • Département de Neurophysiologie Clinique - Hôpital Roger Salengro - CHU Lille
    Lille, France
    Recruiting
    • Philippe Derambure · Contact
  • Hôpital Neurologique Pierre Wertheimer- Service de Neurologie Fonctionnelle et Epileptologie - Hospices Civils Lyon
    Lyon, France
    Not yet recruiting
    • Alexandra Montavont · Contact
  • Service Epilptologie et Rythmologie Cérébrale
    Marseille, France
    Recruiting
  • Service de Neurologie - Hôpital central -CHU Nancy
    Nancy, France
    Not yet recruiting
    • Louis Maillard · Contact
  • Département de Neurologie - Hôpital de la Pitié-Salpêtrière - APHP
    Paris, France
    Not yet recruiting
    • Vincent Navarro · Contact
  • Service de Neurochirurgie -GHU Sainte-Anne
    Paris, France
    Not yet recruiting
    • Elisabeth Landré · Contact
  • Service de Neurologie - Fondation ophtalmologique de Rothschild - Fondation Rothschild
    Paris, France
    Recruiting
    • Anca Nica · Contact
  • Service de Neurologie - CHU de Rennes
    Rennes, France
    Not yet recruiting
    • Mihai Dragos-Millia · Contact
  • Service de Neurologie - Hôpitaux Universitaires, Hôpital de Hautepierre
    Strasbourg, France
    Recruiting
    • Edouard Hirsch · Contact
  • Explorations Neurophysiologiques, Pôle des Neurosciences - Hôpital Pierre Paul Riquet, Purpan
    Toulouse, France
    Not yet recruiting
    • Marie Denuelle · Contact
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2023 (actual). Primary completion is estimated for Mar 2027, 48 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 25, 2022
First posted
Nov 8, 2022
StartActual
Mar 30, 2023
Primary completionEst.
Mar 30, 2027
CompletionEst.
Nov 30, 2027
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date and site details
1 update, last Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    Minor edits only
    + 2 other changes: verification date and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT05609084
Responsible party
Sponsor
First posted
Nov 8, 2022
Start date
Mar 30, 2023
Primary completion
Mar 30, 2027 (estimated)
Completion
Nov 30, 2027 (estimated)
Last update
Nov 20, 2026

Study contacts

Veronique Sabadell
Contact
veronique.sabadell@ap-hm.fr
0491385298 ext. 33
Francois CREMIEUX
study director · AP-HM

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion